Corteva, Inc. $CTVA Stock Holdings Increased by California Public Employees Retirement System

Key Points

• California Public Employees Retirement System increased its stake in Corteva by 9.1% to 1,345,694 shares (about 0.20% of the company), adding 112,028 shares valued at roughly $91.0 million in Q3.
• Corteva reported quarterly EPS of $0.22 (meeting estimates) but revenue of $3.91 billion missed expectations, and the company set FY2026 guidance at 3.450–3.700 EPS.
• Insider Brian Titus sold 8,311 shares for about $636,000—cutting his stake by roughly 50%—while institutional investors hold about 81.54% of the stock and insiders own 0.15%.

California Public Employees Retirement System grew its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 9.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 1,345,694 shares of the company's stock after acquiring an additional 112,028 shares during the quarter. California Public Employees Retirement System owned about 0.20% of Corteva worth $91,009,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Empirical Finance LLC raised its stake in shares of Corteva by 0.6% during the second quarter. Empirical Finance LLC now owns 24,935 shares of the company's stock valued at $1,858,000 after purchasing an additional 153 shares in the last quarter. Fox Run Management L.L.C. grew its position in Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company's stock valued at $227,000 after buying an additional 164 shares in the last quarter. IFG Advisory LLC grew its position in Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company's stock valued at $660,000 after buying an additional 166 shares in the last quarter. Kelleher Financial Advisors increased its stake in Corteva by 3.8% during the 3rd quarter. Kelleher Financial Advisors now owns 4,594 shares of the company's stock valued at $311,000 after buying an additional 170 shares during the period. Finally, United Community Bank raised its position in shares of Corteva by 10.5% during the 3rd quarter. United Community Bank now owns 1,849 shares of the company's stock worth $125,000 after buying an additional 176 shares in the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company's stock, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.15% of the stock is currently owned by company insiders.

Corteva Stock Down 0.0%

Shares of Corteva stock opened at $79.18 on Tuesday. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90. The firm has a market capitalization of $53.25 billion, a PE ratio of 50.11, a price-to-earnings-growth ratio of 2.71 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock's fifty day moving average is $74.33 and its 200-day moving average is $69.20.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts' consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva's revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva's dividend payout ratio (DPR) is presently 45.57%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Jefferies Financial Group upped their price target on shares of Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a research note on Monday, March 2nd. The Goldman Sachs Group reiterated a "buy" rating and set a $88.00 price objective on shares of Corteva in a research note on Thursday, February 5th. JPMorgan Chase & Co. cut Corteva from an "overweight" rating to a "neutral" rating and boosted their target price for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. UBS Group downgraded Corteva from a "buy" rating to a "hold" rating in a research report on Monday, February 9th. Finally, Argus upgraded Corteva to a "strong-buy" rating in a research report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $82.90.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.